ECSP982645A - COMBINATION THERAPY - Google Patents

COMBINATION THERAPY

Info

Publication number
ECSP982645A
ECSP982645A ECSP982645A ECSP982645A EC SP982645 A ECSP982645 A EC SP982645A EC SP982645 A ECSP982645 A EC SP982645A EC SP982645 A ECSP982645 A EC SP982645A
Authority
EC
Ecuador
Prior art keywords
combinations
hypertension
additive
subjects
pharmaceutically acceptable
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Jan Buch
Robert Andrew Donald Scott
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP982645 priority Critical patent/ECSP982645A/en
Publication of ECSP982645A publication Critical patent/ECSP982645A/en

Links

Abstract

Esta invención se refiere a combinaciones farmacéuticas de amlopidino o una sal de adición de ácidos farmacéuticamente aceptables de las mismas, estuches que contienen tales combinaciones y procedimientos de uso de tales combinaciones para tratar sujetos que padecen angina de pecho, asteroclerosis hipertensión e hiperlipidemia combinadas y para tratar sujetos que presentan síntomas de riesgo cardiaco incluyendo humanos. Esta invención también se refiere a combinaciones aditivas y sinégicas de amlodipino o una sal de adición de ácidos farmacéuticamente aceptables de las mismas siendo estas combinaciones aditivas y sinérgicas útiles en el tratamiento de sujetos que padezcan angina de pecho, aterosclerosis, hipertensión e hiperlipidemia combinadas y de aquellos sujetos que presentan sintomas de riesgo cardiaco, incluendo humanos.This invention relates to pharmaceutical combinations of amlopidine or a pharmaceutically acceptable acid addition salt thereof, kits containing such combinations, and methods of using such combinations to treat subjects suffering from angina pectoris, asteroclerosis, hypertension, and hyperlipidemia combined and for treating subjects presenting cardiac risk symptoms including humans. This invention also relates to additive and synergistic combinations of amlodipine or a pharmaceutically acceptable acid addition salt thereof, these additive and synergistic combinations being useful in the treatment of subjects suffering from angina, atherosclerosis, hypertension and hyperlipidemia combined and those subjects who present symptoms of cardiac risk, including humans.

ECSP982645 1998-08-28 1998-08-28 COMBINATION THERAPY ECSP982645A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP982645 ECSP982645A (en) 1998-08-28 1998-08-28 COMBINATION THERAPY

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP982645 ECSP982645A (en) 1998-08-28 1998-08-28 COMBINATION THERAPY

Publications (1)

Publication Number Publication Date
ECSP982645A true ECSP982645A (en) 1999-02-22

Family

ID=42043565

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP982645 ECSP982645A (en) 1998-08-28 1998-08-28 COMBINATION THERAPY

Country Status (1)

Country Link
EC (1) ECSP982645A (en)

Similar Documents

Publication Publication Date Title
CO4970724A1 (en) COMBINATION THERAPY
MY123993A (en) Therapeutic combinations
CO4970726A1 (en) COMBINATION PINE AND ATORVASTATINE THERAPY USEFUL IN THE TREATMENT OF CHEST ANGINA, ATHEROSCLEROSIS, HYPERTENSION AND HYPERLIPIDEMIA
EA200300155A1 (en) THERAPEUTIC COMBINATION OF THE CETR AND ATORVASTATIN INHIBITOR
PT1014961E (en) TREATMENT OF ENXAQUECA ECHUSIA USING METOCLOPRAMIDE AND A NSAID
DE60035870D1 (en) COMBINATION THERAPY FOR WEIGHT REDUCTION AND FAT TREATMENT TREATMENT
UY27402A1 (en) PHARMACEUTICAL COMPOSITIONS OF AMLODIPINE AND ATORVASTATIN
BRPI0408500A (en) Type 1 diabetes treatment with pde5 inhibitors
ECSP982645A (en) COMBINATION THERAPY
BR0116554A (en) Compound, pharmaceutical composition for the treatment of angina or hypertension, process, process for the treatment or prevention of angina or hypertension, composition of the pharmaceutically active ingredient and pharmaceutical composition for the treatment or prevention of angina or hypertension
BR9809376A (en) Pregnan-3-ol-20-ones
ECSP982647A (en) COMBINATION THERAPY
ECSP982646A (en) THERAPEUTIC COMBINATIONS
UY27510A1 (en) COMBINATION THERAPY
ECSP003493A (en) MUTUAL PROPHARMACES OF AMLODIPINO AND ATORVASTATIN